Richard Doubleday, EVP Chief Commercial Officer at DEXCOM INC (DXCM), sold 3,832 shares at $154.99 ($588K) on 2019-07-23, disclosed to the SEC on 2019-07-24.
Seasonal sale ($588k) by EVP Chief Commercial Officer — this insider has traded DXCM in July in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.29 | 980 | $149K | 25.4% |
| 2 | $152.29 | 980 | $149K | 25.4% |
| 3 | $153.78 | 200 | $31K | 5.2% |
| 4 | $154.99 | 836 | $130K | 22.0% |
| 5 | $154.99 | 836 | $130K | 22.0% |
| Total | $153.55 avg | 3,832 |
| $588K |
| 100% |
| Filing → |
| DXCM | SELL | 2021-01-25 | $815K | — | Filing → |
| DXCM | SELL | 2021-01-06 | $8.1M | — | Filing → |
| DXCM | SELL | 2020-12-28 | $661K | — | Filing → |